Given the various strategic initiatives undertaken by Questcor management over the past few years and particularly since the debacle on share price (THE OPPORTUNITY FOR MANY OF US), we are ONLY IN INNING 3 in the overall prospects for this amazing opportunity. I truly believe that if people hang on for another couple of years that they will see another 4-6X from current price and that only allows for just some of their strategic initiatives (e.g., yesterday's PULMONARY announcement) to come to fruition. Current P/E is absolutely ludicrous for a company with both the performance over the past few years AND THE PROSPECTS FOR FUTURE DEVELOPMENTS. If QCOR was just a development stage company and all the clinical prospects were still to be fulfilled, it would probably be trading higher than it is today.
The "One Trick Pony" here is a myth of almost biblical proportions as they continue to develop the 19 approved indications as they seek still others (LIKE ALS) for development. Icing on this cake will come when one of the current or exploratory indications qualifies for another round of ORPHAN PROTECTIONS!!!
AND while Q2 2013 will be great...H2 2013 WILL BE SPECTACULAR AND DISMISS ALL residual concerns about this "One Trick Pony's" future. I have been on H2 back end loading as massively bolstered rep population hits their stride out in the market for their clinical segments.